Summary: Researchers introduce “apical hypercontextualisation”—a bottom-up neurobiological mechanism explaining how psychedelics (psilocybin, LSD, DMT, mescaline) transform perception and cognition. Moving beyond macro-scale whole-brain neuroimaging, the framework focuses on the cellular…
Category: psychopharmacology
THC Significantly Reduces Trauma Nightmares in PTSD
Summary: Researchers investigated the efficacy of dronabinol, a plant-derived tetrahydrocannabinol (THC) formulation, in treating trauma-related nightmares in patients with post-traumatic stress disorder (PTSD). The trial demonstrated a statistically significant reduction…
Psilocybin Therapy Drives 75% PTSD Remission
Summary: The first U.S. clinical trial evaluating psilocybin-assisted therapy in military veterans with treatment-resistant post-traumatic stress disorder (PTSD) has demonstrated significant safety and clinical efficacy. The 11-week pilot trial combined…
Psychedelic Trips Can Halt Political Hate
Summary: A massive study tracking 21,990 U.S. adults has demonstrated that the specific cultural and political atmosphere surrounding a psychedelic experience can systematically pivot its psychological aftermath. Participants whose most…
Single Psilocybin Dose Sparks Rapid Depression Remission
Summary: A Phase 2 randomized clinical trial demonstrates that a single 25 mg dose of psilocybin, combined with psychotherapeutic support, provides rapid, statistically significant, and clinically meaningful reduction in symptoms…
How Scientists Cracked the Ketamine Code for Depression
Summary: Ketamine has been a “miracle” for many with treatment-resistant depression, but its side effects and short duration have limited its use. Two new studies have “reverse engineered” exactly how…
Healing Without the Hallucinations: The Next Generation of Psilocybin Therapy
Summary: While psilocybin is hailed as a breakthrough for depression and anxiety, many patients remain wary of the intense “trips” associated with the drug. Now, researchers have engineered modified versions…
Psychedelics Remodel Myelin to Heal PTSD
Summary: For years, scientists have focused on how psychedelics “rewire” neurons. But a groundbreaking study has found a “missing link” in long-term PTSD recovery: myelin remodeling. Researchers discovered that psilocybin…
Moving Beyond Dopamine to Treat Schizophrenia
Summary: Schizophrenia treatment has been dominated by dopamine-targeting drugs for decades, but these often fail to address the debilitating cognitive and negative symptoms of the disorder. A comprehensive review synthesizes…
Single DMT Dose Provides Lasting Relief from Depression
Summary: While psychedelic research often focuses on hours-long “trips” with psilocybin or LSD, a landmark Phase IIa trial has proven that a much shorter experience can be just as potent.…
